Chapter 19: Adrenergic-Blocking Drugs

Alpha-adrenergic blockers such as prazosin, doxazosin, and tamsulosin function primarily through peripheral vasodilation, reducing vascular resistance and lowering blood pressure, making them valuable therapeutic options for hypertension management and benign prostatic hyperplasia treatment by relaxing smooth muscle in the prostate and bladder neck. Beta-adrenergic blockers including metoprolol, atenolol, propranolol, carvedilol, and labetalol produce their effects by decreasing heart rate, myocardial contractility, and atrioventricular conduction velocity, thereby reducing cardiac workload and oxygen demand in conditions such as hypertension, angina pectoris, acute myocardial infarction, cardiac dysrhythmias, and heart failure. A critical distinction exists between cardioselective beta1 blockers, which preferentially target cardiac tissue, and nonselective agents that inhibit both beta1 and beta2 receptors, the latter carrying increased risk of bronchoconstriction in asthmatic patients, hypoglycemia masking in diabetic patients, and metabolic complications. The chapter addresses important adverse effects and nursing considerations including the first-dose phenomenon characterized by syncope with initial alpha-blocker administration, rebound hypertension resulting from abrupt beta-blocker discontinuation, and contraindications in patients with reactive airway disease, severe bradycardia, or decompensated heart failure. Comprehensive nursing care encompasses vigilant hemodynamic monitoring including blood pressure measurement and apical pulse assessment, metabolic surveillance particularly glucose monitoring in diabetic patients, patient education emphasizing medication adherence and gradual dose tapering protocols, counseling regarding orthostatic precautions with position changes, and alcohol avoidance due to additive hypotensive effects. Understanding receptor selectivity, pharmacokinetic properties, and drug-specific adverse reaction profiles enables nurses to maximize therapeutic efficacy while preventing harmful complications.